INFUSYSTEM HOLDINGS INC (INFU) Stock Fundamental Analysis
NYSEARCA:INFU - NYSE Arca - US45685K1025 - Common Stock - Currency: USD
Taking everything into account, INFU scores 6 out of 10 in our fundamental rating. INFU was compared to 102 industry peers in the Health Care Providers & Services industry. INFU scores excellent on profitability, but there are some minor concerns on its financial health. INFU is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! These ratings could make INFU a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
In the past year INFU was profitable.
In the past year INFU had a positive cash flow from operations.
INFU had positive earnings in each of the past 5 years.
INFU had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of INFU (3.06%) is better than 64.71% of its industry peers.
INFU's Return On Equity of 5.78% is fine compared to the rest of the industry. INFU outperforms 62.75% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.47%, INFU is in the better half of the industry, outperforming 72.55% of the companies in the same industry.
INFU had an Average Return On Invested Capital over the past 3 years of 3.86%. This is significantly below the industry average of 9.62%.
The 3 year average ROIC (3.86%) for INFU is below the current ROIC(7.47%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.06% | ||
| ROE | 5.78% | ||
| ROIC | 7.47% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
1.3 Margins
INFU's Profit Margin of 2.32% is fine compared to the rest of the industry. INFU outperforms 62.75% of its industry peers.
INFU's Profit Margin has been stable in the last couple of years.
INFU has a Operating Margin of 6.07%. This is in the better half of the industry: INFU outperforms 63.73% of its industry peers.
In the last couple of years the Operating Margin of INFU has grown nicely.
INFU has a Gross Margin of 53.13%. This is in the better half of the industry: INFU outperforms 78.43% of its industry peers.
INFU's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.07% | ||
| PM (TTM) | 2.32% | ||
| GM | 53.13% |
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
2. Health
2.1 Basic Checks
INFU has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, INFU has more shares outstanding
INFU has more shares outstanding than it did 5 years ago.
The debt/assets ratio for INFU has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.56 indicates that INFU is not a great score, but indicates only limited risk for bankruptcy at the moment.
INFU's Altman-Z score of 2.56 is in line compared to the rest of the industry. INFU outperforms 56.86% of its industry peers.
The Debt to FCF ratio of INFU is 12.54, which is on the high side as it means it would take INFU, 12.54 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 12.54, INFU perfoms like the industry average, outperforming 44.12% of the companies in the same industry.
INFU has a Debt/Equity ratio of 0.52. This is a neutral value indicating INFU is somewhat dependend on debt financing.
INFU's Debt to Equity ratio of 0.52 is fine compared to the rest of the industry. INFU outperforms 60.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 12.54 | ||
| Altman-Z | 2.56 |
ROIC/WACC0.89
WACC8.36%
2.3 Liquidity
INFU has a Current Ratio of 2.21. This indicates that INFU is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.21, INFU is in the better half of the industry, outperforming 77.45% of the companies in the same industry.
A Quick Ratio of 1.83 indicates that INFU should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.83, INFU is in the better half of the industry, outperforming 70.59% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.83 |
3. Growth
3.1 Past
INFU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 6900.00%, which is quite impressive.
INFU shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.59% yearly.
The Revenue has been growing slightly by 7.98% in the past year.
The Revenue has been growing by 10.70% on average over the past years. This is quite good.
EPS 1Y (TTM)6900%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%80%
Revenue 1Y (TTM)7.98%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%8.5%
3.2 Future
The Earnings Per Share is expected to grow by 84.76% on average over the next years. This is a very strong growth
Based on estimates for the next years, INFU will show a quite strong growth in Revenue. The Revenue will grow by 8.03% on average per year.
EPS Next Y80.2%
EPS Next 2Y84.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.04%
Revenue Next 2Y8.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 44.36, INFU can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of INFU is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 26.31. INFU is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 18.19, which indicates a rather expensive current valuation of INFU.
Based on the Price/Forward Earnings ratio, INFU is valued a bit cheaper than the industry average as 64.71% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of INFU to the average of the S&P500 Index (22.13), we can say INFU is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.36 | ||
| Fwd PE | 18.19 |
4.2 Price Multiples
83.33% of the companies in the same industry are more expensive than INFU, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as INFU.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 56.92 | ||
| EV/EBITDA | 7.29 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of INFU may justify a higher PE ratio.
A more expensive valuation may be justified as INFU's earnings are expected to grow with 84.76% in the coming years.
PEG (NY)0.55
PEG (5Y)4.19
EPS Next 2Y84.76%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for INFU!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.21
+0.11 (+1.8%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners78.82%
Inst Owner Change-0.34%
Ins Owners3.62%
Ins Owner Change0.69%
Market Cap130.29M
Analysts84
Price Target13.9 (123.83%)
Short Float %2.04%
Short Ratio2.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.72%
Min EPS beat(2)-48.06%
Max EPS beat(2)75.49%
EPS beat(4)2
Avg EPS beat(4)7.91%
Min EPS beat(4)-48.06%
Max EPS beat(4)75.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-4.92%
Max Revenue beat(2)0.99%
Revenue beat(4)2
Avg Revenue beat(4)-1.04%
Min Revenue beat(4)-4.92%
Max Revenue beat(4)0.99%
Revenue beat(8)5
Avg Revenue beat(8)0.79%
Revenue beat(12)6
Avg Revenue beat(12)-0.71%
Revenue beat(16)7
Avg Revenue beat(16)-1.97%
PT rev (1m)-3.54%
PT rev (3m)-3.54%
EPS NQ rev (1m)-5%
EPS NQ rev (3m)-20.4%
EPS NY rev (1m)0%
EPS NY rev (3m)-35.4%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)0.92%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 44.36 | ||
| Fwd PE | 18.19 | ||
| P/S | 0.95 | ||
| P/FCF | 56.92 | ||
| P/OCF | 5.96 | ||
| P/B | 2.36 | ||
| P/tB | 2.88 | ||
| EV/EBITDA | 7.29 |
EPS(TTM)0.14
EY2.25%
EPS(NY)0.34
Fwd EY5.5%
FCF(TTM)0.11
FCFY1.76%
OCF(TTM)1.04
OCFY16.78%
SpS6.56
BVpS2.63
TBVpS2.16
PEG (NY)0.55
PEG (5Y)4.19
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.06% | ||
| ROE | 5.78% | ||
| ROCE | 9.46% | ||
| ROIC | 7.47% | ||
| ROICexc | 7.6% | ||
| ROICexgc | 8.58% | ||
| OM | 6.07% | ||
| PM (TTM) | 2.32% | ||
| GM | 53.13% | ||
| FCFM | 1.66% |
ROA(3y)1.04%
ROA(5y)4.49%
ROE(3y)1.93%
ROE(5y)10.25%
ROIC(3y)3.86%
ROIC(5y)4.73%
ROICexc(3y)3.88%
ROICexc(5y)5.02%
ROICexgc(3y)4.43%
ROICexgc(5y)5.92%
ROCE(3y)4.88%
ROCE(5y)5.98%
ROICexcg growth 3Y31.39%
ROICexcg growth 5Y0.4%
ROICexc growth 3Y34.21%
ROICexc growth 5Y4.6%
OM growth 3Y22.87%
OM growth 5Y3.29%
PM growth 3Y7.83%
PM growth 5Y0.72%
GM growth 3Y-3.89%
GM growth 5Y-2.01%
F-Score9
Asset Turnover1.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | 12.54 | ||
| Debt/EBITDA | 1.35 | ||
| Cap/Depr | 151.51% | ||
| Cap/Sales | 14.23% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 102.77% | ||
| Profit Quality | 71.76% | ||
| Current Ratio | 2.21 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 2.56 |
F-Score9
WACC8.36%
ROIC/WACC0.89
Cap/Depr(3y)114.8%
Cap/Depr(5y)115.78%
Cap/Sales(3y)11.93%
Cap/Sales(5y)13.88%
Profit Quality(3y)4561.75%
Profit Quality(5y)2764.31%
High Growth Momentum
Growth
EPS 1Y (TTM)6900%
EPS 3Y12.62%
EPS 5Y10.59%
EPS Q2Q%80%
EPS Next Y80.2%
EPS Next 2Y84.76%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)7.98%
Revenue growth 3Y9.62%
Revenue growth 5Y10.7%
Sales Q2Q%8.5%
Revenue Next Year8.04%
Revenue Next 2Y8.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y149.37%
EBIT growth 3Y34.69%
EBIT growth 5Y14.35%
EBIT Next Year297.98%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y177.23%
FCF growth 3Y16.52%
FCF growth 5YN/A
OCF growth 1Y64.52%
OCF growth 3Y3.76%
OCF growth 5Y8.08%